ETF Managers Group’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-18,958
Closed -$270K 835
2022
Q2
$270K Buy
+18,958
New +$270K 0.01% 617
2021
Q2
Sell
-33,930
Closed -$945K 804
2021
Q1
$945K Buy
+33,930
New +$945K 0.02% 280